EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR-93 Attenuates CALR Mutant-Driven Oncogenic Activity in Myeloproliferative Neoplasms

Ying-Hsuan Wang, Wei-Chi Tang, Ying-Ju Chen, Cih-En Huang, Yi-Yang Chen, Yu-Ying Wu, Yao-Ren Yang, Chia-Hung Wu, Wen-Yung Tsai, Hsing-Yi Tsou, Chih-Cheng Chen

International Journal of Molecular Sciences · 19.11.2026 · 27 (22) · 10390

DOI: 10.3390/ijms272210390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.11.2026. Verfasst von Ying-Hsuan Wang und 10 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Chang-Gung Memorial Hospital.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High Mobility Group AT-hook 2 (HMGA2), a recognized oncogene in myeloproliferative neoplasm (MPN), is regulated by dozens of microRNAs (miRNAs), notably, let-7a. We hypothesize that other miRNAs might influence HMGA2-associated phenotypic characteristics in MPN, as well. To explore further, we applied a miRNA library screening system to identify potential HMGA2 mRNA 3′-untranslated region (3′UTR)-targeting candidates and evaluated their functional effects in MPN cell models. MicroRNA-93 (miR-93) was among the few HMGA2 3′UTR-targeting miRNAs differentially expressed in MPN cells, being downregulated in CALR-mutated cells but not in JAK2V617F-mutated cells. Correspondingly, HMGA2 overexpression was observed in CALR-mutated cells. Luciferase reporter assays confirmed that miR-93 could target a highly conserved sequence within the HMGA2 3′UTR region. Upregulation of miR-93 in CALR-mutated cells significantly impeded cellular growth and increased apoptosis in vitro. Rapid development of myelofibrosis phenotypes was observed in immune-deficient mice transplanted with CALR-mutated cells. Ectopic expression of miR-93 in these cells attenuated myelofibrosis-like phenotypes in vivo and prolonged the survival of these mice. Clinically, higher miR-93 expression was associated with features suggesting a more indolent disease course in a small cohort of CALR-mutated MPN patients, although these observations were exploratory. Collectively, our experimental findings support a potential tumor-suppressive role for miR-93 in CALR-mutated MPN, while the clinical associations require further validation in larger patient cohorts.

Förderung

  • National Science and Technology Council
  • Chang-Gung Memorial Hospital

Zitieren

APA

Wang, Y., Tang, W., Chen, Y., Huang, C., Chen, Y., Wu, Y., Yang, Y., Wu, C., Tsai, W., Tsou, H., & Chen, C. (2026). MiR-93 Attenuates CALR Mutant-Driven Oncogenic Activity in Myeloproliferative Neoplasms. International Journal of Molecular Sciences, 27(22), 10390. https://doi.org/10.3390/ijms272210390

Vancouver

Wang Y, Tang W, Chen Y, Huang C, Chen Y, Wu Y, et al. MiR-93 Attenuates CALR Mutant-Driven Oncogenic Activity in Myeloproliferative Neoplasms. International Journal of Molecular Sciences. 2026;27(22):10390. doi:10.3390/ijms272210390

BibTeX
@article{Wang2026,
  author = {Wang, Ying-Hsuan and Tang, Wei-Chi and Chen, Ying-Ju and Huang, Cih-En and Chen, Yi-Yang and Wu, Yu-Ying and Yang, Yao-Ren and Wu, Chia-Hung and Tsai, Wen-Yung and Tsou, Hsing-Yi and Chen, Chih-Cheng},
  title = {MiR-93 Attenuates CALR Mutant-Driven Oncogenic Activity in Myeloproliferative Neoplasms},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {22},
  pages = {10390},
  doi = {10.3390/ijms272210390}
}
Kostenlos starten →